Pandameds.Com Editorial Team
The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.
Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.
Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers
Recent Blog Post
Trulicity Side Effects: Complete Guide with Clinical Data & Management Timeline
According to clinical trial data, gastrointestinal side effects are the most frequently reported adverse reactions with Trulicity (1.5 mg). Nausea affects up to 21.1% of patients, while diarrhea, vomiting, and abdominal pain each occur in 9-13% of users. These side effects of Trulicity are typically mild to moderate and tend to decrease over time as [...]
Rybelsus Dosage: 3mg→7mg→14mg Titration Schedule + Weight Loss Guide
According to the FDA prescribing information, Rybelsus treatment begins with a 3mg starting dose taken once daily for 30 days. This initial dosage is intended for treatment initiation and is not meant for long-term blood sugar control. It primarily helps your body adapt to the medication and reduces gastrointestinal side effects. After the first month, [...]
Rybelsus Cost 2026: $998 List vs $10 Insured + Walmart Pricing Guide
Rybelsus lists at $997.58 monthly for all doses (3mg, 7mg, and 14mg), but with the Novo Nordisk savings card and commercial insurance, the out-of-pocket cost can drop to as low as $10. As the first FDA-approved oral GLP-1 receptor agonist, Rybelsus offers the convenience of a daily pill versus weekly injections like Ozempic or Wegovy, [...]
Victoza vs Saxenda: Same Drug, Different Doses – Diabetes vs Weight Loss Pens
Victoza and Saxenda are both brand-name drugs manufactured by Novo Nordisk that contain the same active ingredient: liraglutide. Despite sharing an identical GLP-1 molecule, these two medications have different FDA approvals and maximum dosing. Victoza (liraglutide 0.6-1.8mg daily) is approved for managing blood sugar levels in adults with type 2 diabetes, while Saxenda (liraglutide 3.0mg [...]
Saxenda Dosage Guide: 0.6mg Start to 3mg Max (5-Week Titration Schedule)
Saxenda dosing starts at 0.6 mg once daily and is gradually increased by 0.6 mg every week until reaching the maintenance dose of 3.0 mg daily-this FDA-approved titration schedule takes approximately 5 weeks to complete. The active ingredient in Saxenda is liraglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk for chronic weight management in [...]
Trulicity vs Zepbound: 4-7% vs 21% Loss – Dual GIP/GLP-1 vs GLP-1
Zepbound delivers dramatically superior weight loss results: participants in clinical trials lost an average of 21% body weight (approximately 48 lbs at the highest dose) compared to Trulicity's modest 4-7% weight loss (7-10 lbs). This substantial difference stems from their fundamentally different mechanisms-Zepbound is a dual GIP and GLP-1 receptor agonist, while Trulicity operates solely [...]
Contrave vs Zepbound 2026: 22.5% vs 8.1% Weight Loss – Pill vs Dual Hormone Injection
Zepbound (tirzepatide) produces approximately 22.5% average total body weight loss at the maximum 15 mg dose over 72 weeks, according to the SURMOUNT-1 clinical trial published in the New England Journal of Medicine. Contrave (naltrexone/bupropion) shows an average of 8.1% total body weight loss at the maximum daily dose over 56 weeks, as documented in [...]
Does Zepbound Cause Depression? No Direct Link + Mood Monitoring Guide
Zepbound (tirzepatide) does not directly cause depression according to clinical evidence. The FDA's comprehensive review of over 107,000 patients found no increased risk of suicidal ideation or behavior (SI/B) associated with GLP-1 receptor agonist medications, including tirzepatide. In January 2026, the FDA requested manufacturers remove the suicide and depression warnings from Zepbound's label based on [...]
Does Zepbound Make You Tired? 10% Fatigue Rate + Complete Recovery Protocol
Zepbound (tirzepatide) can cause fatigue as a side effect, and tiredness is one of the more commonly reported experiences among users. According to FDA prescribing information, fatigue (which includes feelings of weakness, lethargy, and malaise) was reported by 5% of people taking 5 mg, 6% of those on 10 mg, and 7% of those taking [...]
Zepbound Hair Loss: 5% Rate from Rapid Weight Loss Stress – Telogen Effluvium Guide
Yes, Zepbound can cause hair loss, but it affects only about 5% of patients according to FDA clinical trial data. The hair loss associated with Zepbound is not permanent follicle damage-it's a temporary condition called telogen effluvium triggered by rapid weight loss and potential nutritional deficiencies. Women appear to be more affected (7.1%) compared to [...]
